Dublin, Ireland · Europe
69sterile
Oncology
FDAEMAPMDANMPA
SCALE 270 studies
Loading…
Clinical Development
CROs
Clinical research organizations38
CROs listed
Trial management, monitoring, biostatistics and data services — scored on real operational depth, not sales polish.
Scores are deterministic, rules-based — not AI.
OncologyRare disease
FDAEMAMHRA
SCALE 260 studies
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 270 studies
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 230 studies
Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Oncology
EMAFDAMHRA
SCALE 240 studies
FDAPMDA
SCALE 00 studies
Company states Integrated Drug Discovery services span "multiple therapeutic areas including but not limited to oncologyCNSmetabolic disorderspain & inflammation". Programme counts stated on the same page: Oncology 30+
SCALE 00 studies
FDAPMDA
SCALE 00 studies
Company lists: Oncology & HematologyDermatologyNeuroscienceBiosimilar Development
SCALE 270 studies
Company lists: OncologyFibrosisRespiratory DiseasesNeuroscience
SCALE 20 studies
SCALE 00 studies
Company states expertise across oncologycardiologynephrologyurology
SCALE 190 studies
Company site lists OncologyDermatologyRespiratoryBiosimilars and Vaccines as therapeutic areas
SCALE 120 studies
SCALE 190 studies
SCALE 30 studies
SCALE 20 studies
Stated on the company's Who We Are page: "multiple therapeutic areas with a specific focus on Inflammation & PainInfectious DiseasesCentral Nervous systemsand Oncology".
SCALE 00 studies